CDC Issues Alert for Unexplained Hepatitis Cases in Children
The U.S. Centers for Disease Control and Prevention has issued a health advisory urging state and local authorities to watch for cases of hepatitis in children with adenovirus infection. (Source: WebMD Health)
Source: WebMD Health - April 21, 2022 Category: Consumer Health News Source Type: news
CDC Issues Alert for Hepatitis in Children With Adenovirus Infection
The U.S. Centers for Disease Control and Prevention has issued a health advisory urging state and local authorities to watch for cases of hepatitis in children with adenovirus infection. (Source: WebMD Health)
Source: WebMD Health - April 21, 2022 Category: Consumer Health News Source Type: news
CDC issues alert for cluster of severe hepatitis in children
The Centers for Disease Control and Prevention issued a health advisory Thursday after identifying a cluster of hepatitis and adenovirus infections in U.S. children. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 21, 2022 Category: Consumer Health News Source Type: news
Doctors suggest adenovirus link to child hepatitis cases
UK child hepatitis cases rise to 108, with a common virus increasingly likely to be the trigger. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 21, 2022 Category: Consumer Health News Source Type: news
UK officials investigating total of 74 child hepatitis cases
One potential cause could be adenoviruses, but health experts are also looking at links to Covid-19. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 13, 2022 Category: Consumer Health News Source Type: news
UK officials investigate 74 child hepatitis cases
One potential cause could be adenoviruses, but health experts are also looking at links to Covid-19. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 12, 2022 Category: Consumer Health News Source Type: news
Why the UK can ’t rely on boosters to get through each new wave of Covid | Danny Altmann
The evidence suggests performance could be less predictable and effective in the future – though there are promising developmentsDanny Altmann is a professor of immunology at Imperial College LondonThis time in 2020, we watched with horror as the realities of the pandemic and its death toll unfurled. Most hardly dared imagine thateffective vaccines might appear in a fraction of the time taken for previous efforts, effectively stemming the pandemic tide.But despite the success of the vaccines in greatly reducing the odds of hospitalisation or death, viral evolution had plenty more to throw at us. The onslaught of highlyim...
Source: Guardian Unlimited Science - March 28, 2022 Category: Science Authors: Danny Altmann Tags: Immunology Vaccines and immunisation Coronavirus UK news Health Science Society Source Type: news
Valoctocogene Roxaparvovec Evaluated in Severe Hemophilia A
FRIDAY, March 18, 2022 -- For men with severe hemophilia A, treatment with valoctocogene roxaparvovec, an adeno-associated virus 5-based gene-therapy vector, yields a significant increase in factor VIII activity, with a reduction in treated bleeding... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 18, 2022 Category: Pharmaceuticals Source Type: news
Novartis, Voyager Therapeutics reach license option agreement for next-generation gene therapy vectors for neurological diseases
Novartis today announced a license option agreement with Voyager Therapeutics, a gene therapy company focused on next-generation adeno-associated virus (AAV) technologies, for three capsids to use in potential gene therapies for neurological diseases, with options to access capsids for two other targets. (Source: World Pharma News)
Source: World Pharma News - March 8, 2022 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news
German Researchers Develop DNA Origami That Traps and Neutralizes Certain Viruses
This “Virus Trap” might eventually be manufactured by clinical laboratories for the diagnostic process Clinical laboratory managers and pathologists will be fascinated by this new treatment coming out of Germany for viral infections. It’s an entirely different technology approach to locating and neutralizing live viruses that may eventually be able to control anti-viral-resistant strains of […]
The post German Researchers Develop DNA Origami That Traps and Neutralizes Certain Viruses appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - February 18, 2022 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: International Laboratory News Laboratory Instruments & Laboratory Equipment Laboratory Pathology Laboratory Testing Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing Precision Medicine AAV adeno-associated virus anatomic pathol Source Type: news
Small Myocarditis Risk Now Seen for Adenovirus COVID Vaccine Small Myocarditis Risk Now Seen for Adenovirus COVID Vaccine
The large-scale analysis suggests the risk is low with the adenovirus vaccine and pales in comparison to that following a positive SARS-CoV-2 test.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 17, 2021 Category: Cardiology Tags: Cardiology News Source Type: news
Johnson & Johnson Statement on its COVID-19 Vaccine Following CDC ACIP Meeting
NEW BRUNSWICK, N.J., December 16, 2021 – Johnson & Johnson remains confident in the overall positive benefit-risk profile of its COVID-19 vaccine. Studies have shown that the Johnson & Johnson COVID-19 vaccine generates strong antibody and cellular immune responses [i] and long-lasting immune memory[ii] and breadth of protection across variants. In addition, a growing body of evidence is revealing the strength of protection of our vaccine as a booster to either the Janssen COVID-19 vaccine or a different authorized or approved COVID-19 vaccine, both in terms of its efficacy and durability.[iii], [iv], [v], [vi], ...
Source: Johnson and Johnson - December 16, 2021 Category: Pharmaceuticals Source Type: news
Cardiff scientists uncover mechanism that leads to rare blood clots after AstraZeneca vaccine, UK Covid Vaccine Research Hub
A team of scientists from Cardiff University and the US have identified the biological mechanism that causes extremely rare blood clots following a dose of the AstraZeneca vaccine.
The research, published in the journal Science Advances, used a technique called cryo-electron microscopy to capture images of the adenovirus in molecular detail, in a bid to understand what was causing the clots.
Concerns about the rare blood clots have influenced policy decisions about how the vaccine should be used, and led to restrictions on its use in the UK for people under 40. The Cardiff team were given emergency government funding to ...
Source: Current Awareness Service for Health (CASH) - December 2, 2021 Category: Consumer Health News Source Type: news
Covid: scientists find possible trigger for AstraZeneca jab blood clots
Experts hope better understanding of rare side effect of vaccine could help ‘turn the tide’ on pandemicCoronavirus – latest updatesSee all our coronavirus coverageScientists believe they may have found the trigger behind theextremely rare blood clot complications stemming from the Oxford/AstraZeneca ’s Covid vaccine.According to a team of researchers from Cardiff and the US, the reaction can be traced to the way the adenovirus used by the vaccine to shuttle the coronavirus ’s genetic material into cells binds with a specific protein in the blood, known as platelet factor 4 (PF4).Continue reading... (Source: Guard...
Source: Guardian Unlimited Science - December 2, 2021 Category: Science Authors: PA Media Tags: Coronavirus AstraZeneca Vaccines and immunisation Health Infectious diseases Science Microbiology Medical research Society World news Pharmaceuticals industry Business Source Type: news
A New Study Makes the Case for Mixing and Matching the Pfizer-BioNTech, Moderna and J & J Vaccine Doses
As soon as health officials made it clear that the world would need a booster dose of the COVID-19 vaccine, they needed to know if people could mix doses of vaccines made by different manufacturers.
In the first study to provide results on such cross-dosing, researchers say that it’s safe for people who received one of the three vaccines available in the U.S. to get a booster dose of another—and that they found early evidence that certain combinations might generate stronger immune responses than others. The study was published on a preprint server and not yet peer-reviewed, and came on the same day that the Fo...
Source: TIME: Health - October 15, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
